vs
Side-by-side financial comparison of Solana Co (HSDT) and Sensus Healthcare, Inc. (SRTS). Click either name above to swap in a different company.
Solana Co is the larger business by last-quarter revenue ($5.2M vs $4.9M, roughly 1.1× Sensus Healthcare, Inc.). Solana Co runs the higher net margin — 6227.1% vs -64.1%, a 6291.2% gap on every dollar of revenue. On growth, Solana Co posted the faster year-over-year revenue change (2725.9% vs -62.2%). Over the past eight quarters, Solana Co's revenue compounded faster (522.3% CAGR vs -31.9%).
Solana is a Mexican cottage manufacturer of sports, racing, and kids' automobiles based in Mexico City. The family run company has operated since 1936, with a total production of fewer than fifty cars; the majority of them one-offs. The family is heavily involved in motor sports; the most prominent member was Moisés Solana, who raced family-built cars and later in Formula One.
Sensus Healthcare, Inc. is a medical technology company that designs, manufactures and commercializes innovative non-invasive superficial radiation therapy systems. Its products are primarily used for treating non-melanoma skin cancers, keloids, and select cosmetic dermatology conditions, serving healthcare providers and clinical facilities worldwide.
HSDT vs SRTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.2M | $4.9M |
| Net Profit | $325.6M | $-3.2M |
| Gross Margin | 96.6% | 38.4% |
| Operating Margin | -3845.8% | -63.8% |
| Net Margin | 6227.1% | -64.1% |
| Revenue YoY | 2725.9% | -62.2% |
| Net Profit YoY | 8388.0% | -304.9% |
| EPS (diluted) | $111.28 | $-0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.2M | $4.9M | ||
| Q3 25 | $697.0K | $6.9M | ||
| Q2 25 | $43.0K | $7.3M | ||
| Q1 25 | $49.0K | $8.3M | ||
| Q4 24 | $185.0K | $13.1M | ||
| Q3 24 | $51.0K | $8.8M | ||
| Q2 24 | $182.0K | $9.2M | ||
| Q1 24 | $135.0K | $10.7M |
| Q4 25 | $325.6M | $-3.2M | ||
| Q3 25 | $-352.8M | $-943.0K | ||
| Q2 25 | $-9.8M | $-1.0M | ||
| Q1 25 | $-3.8M | $-2.6M | ||
| Q4 24 | — | $1.5M | ||
| Q3 24 | $-3.7M | $1.2M | ||
| Q2 24 | $-1.6M | $1.6M | ||
| Q1 24 | $-2.5M | $2.3M |
| Q4 25 | 96.6% | 38.4% | ||
| Q3 25 | 85.2% | 39.4% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 52.2% | ||
| Q4 24 | 16.8% | 54.4% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | 35.2% | 58.7% | ||
| Q1 24 | 8.9% | 62.5% |
| Q4 25 | -3845.8% | -63.8% | ||
| Q3 25 | -5086.1% | -37.3% | ||
| Q2 25 | -7725.6% | -26.6% | ||
| Q1 25 | -8185.7% | -31.7% | ||
| Q4 24 | — | 13.2% | ||
| Q3 24 | -7980.4% | 16.9% | ||
| Q2 24 | -1796.7% | 21.5% | ||
| Q1 24 | -2530.4% | 27.1% |
| Q4 25 | 6227.1% | -64.1% | ||
| Q3 25 | -50612.3% | -13.7% | ||
| Q2 25 | -22867.4% | -14.2% | ||
| Q1 25 | -7832.7% | -30.8% | ||
| Q4 24 | — | 11.8% | ||
| Q3 24 | -7227.5% | 13.7% | ||
| Q2 24 | -885.7% | 17.4% | ||
| Q1 24 | -1863.7% | 21.3% |
| Q4 25 | $111.28 | $-0.19 | ||
| Q3 25 | $-32.89 | $-0.06 | ||
| Q2 25 | $-79.73 | $-0.06 | ||
| Q1 25 | $-0.51 | $-0.16 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-744.35 | $0.07 | ||
| Q2 24 | $-485.30 | $0.10 | ||
| Q1 24 | $-3.08 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.3M | $22.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $300.9M | $48.1M |
| Total Assets | $303.9M | $53.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.3M | $22.1M | ||
| Q3 25 | $124.1M | $24.5M | ||
| Q2 25 | $6.1M | $22.2M | ||
| Q1 25 | $1.1M | $19.1M | ||
| Q4 24 | $1.1M | $22.1M | ||
| Q3 24 | $3.5M | $22.6M | ||
| Q2 24 | $6.4M | $19.0M | ||
| Q1 24 | $3.6M | $14.7M |
| Q4 25 | $300.9M | $48.1M | ||
| Q3 25 | $-152.4M | $51.2M | ||
| Q2 25 | $6.0M | $52.1M | ||
| Q1 25 | $1.3M | $53.0M | ||
| Q4 24 | $1.1M | $55.8M | ||
| Q3 24 | $3.8M | $54.1M | ||
| Q2 24 | $6.3M | $52.9M | ||
| Q1 24 | $2.0M | $51.2M |
| Q4 25 | $303.9M | $53.0M | ||
| Q3 25 | $475.9M | $58.3M | ||
| Q2 25 | $7.9M | $58.9M | ||
| Q1 25 | $3.5M | $60.2M | ||
| Q4 24 | $3.5M | $62.2M | ||
| Q3 24 | $5.6M | $59.9M | ||
| Q2 24 | $8.8M | $58.2M | ||
| Q1 24 | $5.8M | $57.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.5M | $-2.2M |
| Free Cash FlowOCF − Capex | — | $-2.4M |
| FCF MarginFCF / Revenue | — | -47.9% |
| Capex IntensityCapex / Revenue | — | 3.2% |
| Cash ConversionOCF / Net Profit | -0.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $332.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-16.5M | $-2.2M | ||
| Q3 25 | $-4.0M | $2.3M | ||
| Q2 25 | $-2.8M | $3.1M | ||
| Q1 25 | $-3.5M | $-2.7M | ||
| Q4 24 | $-11.0M | $-827.0K | ||
| Q3 24 | $-2.8M | $4.0M | ||
| Q2 24 | $-2.9M | $4.2M | ||
| Q1 24 | $-3.0M | $-8.2M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | — | $2.3M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | — | $-2.7M | ||
| Q4 24 | $-11.0M | $-1.1M | ||
| Q3 24 | — | $3.6M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | $-3.0M | $-8.4M |
| Q4 25 | — | -47.9% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 42.2% | ||
| Q1 25 | — | -32.2% | ||
| Q4 24 | -5970.8% | -8.6% | ||
| Q3 24 | — | 40.9% | ||
| Q2 24 | — | 45.8% | ||
| Q1 24 | -2226.7% | -79.0% |
| Q4 25 | — | 3.2% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 2.7% | 2.3% | ||
| Q3 24 | 0.0% | 3.8% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 3.7% | 2.2% |
| Q4 25 | -0.05× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.53× | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | — | 2.62× | ||
| Q1 24 | — | -3.60× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HSDT
Segment breakdown not available.
SRTS
| Products | $2.8M | 57% |
| Other | $2.1M | 43% |
